Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
21.42
+1.26 (6.25%)
Aug 7, 2026, 4:00 PM EDT - Market closed
Anika Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Anika Therapeutics stock have an average target of $21, which predicts a -1.96% decrease from the current stock price of 21.42.
Price Target: $21 (-1.96%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Anika Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Nov '25 | Jan '26 | Feb '26 | Apr '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Buy Maintains $18 → $21 | Buy | Maintains | $18 → $21 | -1.96% | Jul 30, 2026 |
| Barrington | Barrington | Buy Maintains $17 → $21 | Buy | Maintains | $17 → $21 | -1.96% | Jul 30, 2026 |
Financial Forecast
Revenue This Year
122.24M
from 112.82M
Increased by 8.35%
Revenue Next Year
128.56M
from 122.24M
Increased by 5.17%
EPS This Year
1.05
from 0.11
Increased by 854.55%
EPS Next Year
0.95
from 1.05
Decreased by -9.52%
EPS and Forward PE are based on non-GAAP adjusted numbers.